相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial (vol 149, pg 521, 2008)
G. Simonneau et al.
ANNALS OF INTERNAL MEDICINE (2009)
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2009)
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation
Benjamin Sztrymf et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era
Olivier Sitbon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Hypoxia during air travel in adults with pulmonary disease
Lawrence C. Mohr
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2008)
Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials
J. Avouac et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Ambrisentan for the treatment of pulmonary arterial hypertension -: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2
Nazzareno Galie et al.
CIRCULATION (2008)
Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension
Xavier Jais et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study):: a double-blind, randomised controlled trial
N. Galie et al.
LANCET (2008)
Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension A Randomized Trial
Gerald Simonneau et al.
ANNALS OF INTERNAL MEDICINE (2008)
Pulmonary diseases and the heart
MeiLan K. Han et al.
CIRCULATION (2007)
A USA-based registry for pulmonary arterial hypertension: 1982-2006
T. Thenappan et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension
C. Tji-Joong Gan et al.
CHEST (2007)
Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension
Gregory D. Lewis et al.
CIRCULATION (2007)
The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted
Sebastien Bonnet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Right ventricular pressure waveform and wave reflection analysis in patients with pulmonary arterial hypertension
Mustafa Karamanoglu et al.
CHEST (2007)
Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment-effects in pulmonary arterial hypertension
Mardi Gomberg-Maitland et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2007)
Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension
Anastasia Anthi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodology
Alejandro Macchia et al.
AMERICAN HEART JOURNAL (2007)
Medical therapy for pulmonary arterial hypertension - Updated ACCP evidence-based clinical practice guidelines
David B. Badesch et al.
CHEST (2007)
Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension
Serge A. van Wolferen et al.
EUROPEAN HEART JOURNAL (2007)
Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis
Steven D. Nathan et al.
CHEST (2007)
Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure
Gregory D. Lewis et al.
CIRCULATION (2007)
Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers
Marius M. Hoeper et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil
R. J. Barst et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension
Vallerie V. McLaughlin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?
Kelly M. Chin et al.
CHEST (2006)
Inhaled iloprost in eight heart transplant recipients presenting with post-bypass acute right ventricular dysfunction
K. Theodoraki et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2006)
Sarcoidosis-associated pulmonary hypertension - Outcome with long-term epoprostenol treatment
Kimberly A. Fisher et al.
CHEST (2006)
Right ventricular function and failure - Report of a National Heart, lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure
Norbert F. Voelkel et al.
CIRCULATION (2006)
Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension
Derliz Mereles et al.
CIRCULATION (2006)
Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
M. M. Hoeper et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Pulmonary arterial hypertension
Vallerie V. McLaughlin et al.
CIRCULATION (2006)
Preoperative pulmonary hypertension is associated with postoperative left ventricular dysfunction in chronic organic mitral regurgitation: An echocardiographic and hemodynamic study
Hua Yang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2006)
Bosentan therapy in patients with Eisenmenger syndrome - A multicenter, double-blind, randomized, placebo-controlled study
Nazzareno Galie et al.
CIRCULATION (2006)
Biomarkers in acute cardiac disease - The present and the future
Allan S. Jaffe et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Systemic sclerosis associated pulmonary hypertension: improved survival in the current era
M. H. Williams et al.
HEART (2006)
An abnormal mitochondrial-hypoxia inducible factor-1α-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats -: Similarities to human pulmonary arterial hypertension
Sébastien Bonnet et al.
CIRCULATION (2006)
Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension
C. Gregory Elliott et al.
CIRCULATION (2006)
Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension
Christophe Guignabert et al.
CIRCULATION RESEARCH (2006)
Outcome of watchful waiting in asymptomatic severe mitral regurgitation
R Rosenhek et al.
CIRCULATION (2006)
A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease
BP Madden et al.
VASCULAR PHARMACOLOGY (2006)
Pulmonary arterial hypertension in France - Results from a national registry
M Humbert et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension
Anna Fijalkowska et al.
CHEST (2006)
Chronic thromboembolic pulmonary hypertension
MM Hoeper et al.
CIRCULATION (2006)
Risk factors for reperfusion injury after lung transplantation
SR Cottini et al.
INTENSIVE CARE MEDICINE (2006)
Safety and efficacy of IV treprostinil for pulmonary arterial hypertension - A prospective, multicenter, open-label, 12-week trial
VF Tapson et al.
CHEST (2006)
Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension
S Provencher et al.
EUROPEAN HEART JOURNAL (2006)
Initial experience with bosentan therapy in patients considered ineligible for heart transplantation because of severe pulmonary hypertension
F Perez-Villa et al.
CLINICAL TRANSPLANTATION (2006)
Sildenafil improves hemodynamic parameters in COPD - an investigation of six patients
S. Alp et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2006)
Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension
M Gomberg-Maitland et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
O Sitbon et al.
THORAX (2005)
Early detection of pulmonary arterial hypertension in systemic sclerosis -: A French nationwide prospective multicenter study
E Hachulla et al.
ARTHRITIS AND RHEUMATISM (2005)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension
CF Opitz et al.
EUROPEAN HEART JOURNAL (2005)
Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults
F Santini et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Effects of long-term bosentan in children with pulmonary arterial hypertension
EB Rosenzweig et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Ambrisentan therapy for pulmonary arterial hypertension
N Galié et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Mild vs severe pulmonary hypertension before heart transplantation: Different effects on posttransplantation pulmonary hypertension and mortality
PP Chang et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Surgical and interventional therapies for pulmonary arterial hypertension
JK Olsson et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Severe pulmonary hypertension and chronic obstructive pulmonary disease
A Chaouat et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension
O Sitbon et al.
CIRCULATION (2005)
Continuous haemodynamic monitoring during exercise in patients with pulmonary hypertension
M Wonisch et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Severe left ventricular dysfunction secondary to primary pulmonary hypertension: Bridging therapy with bosentan before lung transplantation
AE Brauchlin et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation
G Thabut et al.
CHEST (2005)
Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics
AF Shorr et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Role of inhaled nitric oxide in adult heart or lung transplant recipients
RS Rea et al.
ANNALS OF PHARMACOTHERAPY (2005)
Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hepertension - Combined administration with inhaled nitric oxide
JJ Lepore et al.
CHEST (2005)
Hemodynamic observations in two pulmonary hypertensive patients changing treatment from inhaled iloprost to the oral endothelin-antagonist bosentan
FM Fruhwald et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement
K Fattouch et al.
JOURNAL OF CARDIAC SURGERY (2005)
Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension
JD Cogan et al.
GENETICS IN MEDICINE (2005)
Repair of congenital heart lesions combined with lung transplantation for the treatment of severe pulmonary hypertension: A 13-year experience
CK Choong et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2005)
Survival with first-line bosentan in patients with primary pulmonary hypertension
VV McLaughlin et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Oral sildenafil reduces pulmonary hypertension after cardiac surgery
AL Trachte et al.
ANNALS OF THORACIC SURGERY (2005)
Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle
J West et al.
CIRCULATION RESEARCH (2004)
Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension
J Morales-Blanhir et al.
RESPIRATORY MEDICINE (2004)
Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia
SA Abdalla et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Pulmonary hypertension as a risk factor for death in patients with sickle cell disease
MT Gladwin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Sitaxsentan therapy for pulmonary arterial hypertension
RJ Barst et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Endothelin expression and the progression of heart failure - Exemplifying the vagaries of therapeutic development
MA Konstam et al.
CIRCULATION (2004)
BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease
KE Roberts et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Biventricular support with the Jarvik 2000 ventricular assist device in a calf model of pulmonary hypertension
M Kindo et al.
ASAIO JOURNAL (2004)
Combination of bosentan with epoprostenol in pulmonary arterial hypertension:: BREATHE-2
M Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension
HH Leuchte et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Outcomes in children with idiopathic pulmonary arterial hypertension
D Yung et al.
CIRCULATION (2004)
Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin®) administered by the intravenous and subcutaneous route to normal volunteers
K Laliberte et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension
O Sitbon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension -: art. no. e127
R Koehler et al.
JOURNAL OF MEDICAL GENETICS (2004)
Screening, early detection, and diagnosis of pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines
M McGoon et al.
CHEST (2004)
Prognosis of pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines
VV McLaughlin et al.
CHEST (2004)
Potential role for sildenafil in the management of perioperative pulmonary hypertension and right ventricular dysfunction after cardiac surgery
BP Madden et al.
BRITISH JOURNAL OF ANAESTHESIA (2004)
Guidelines on diagnosis and treatment of pulmonary arterial hypertension -: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology
N Galiè et al.
EUROPEAN HEART JOURNAL (2004)
Pulmonary artery hypertension and sleep-disordered breathing - ACCP evidence-based clinical practice guidelines
CW Atwood et al.
CHEST (2004)
Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure
J Alaeddini et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Surgical treatments/interventions for pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines
RL Doyle et al.
CHEST (2004)
Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension
N Galiè et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Cellular and molecular pathobiology of pulmonary arterial hypertension
M Humbert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Interventional and surgical modalities of treatment for pulmonary arterial hypertension
W Klepetko et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Pathologic assessment of vasculopathies in pulmonary hypertension
GG Pietra et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Clinical classification of pulmonary hypertension
G Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Mechanisms of disease: Pulmonary arterial hypertension
HW Farber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism
V Pengo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Diastolic heart failure - Abnormalities in active relaxation and passive stiffness of the left ventricle
MR Zile et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease
S Eddahibi et al.
CIRCULATION (2003)
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial
S Yusuf et al.
LANCET (2003)
Atrial septostomy in the treatment of severe pulmonary arterial hypertension
F Reichenberger et al.
THORAX (2003)
Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension
A Torbicki et al.
CIRCULATION (2003)
Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension
E Marcos et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension
H Nunes et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Medical progress: Heart failure
M Jessup et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension
AL Hinderliter et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Advances in the treatment of secondary pulmonary hypertension
JP Maloney
CURRENT OPINION IN PULMONARY MEDICINE (2003)
Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease
SM Arcasoy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol
KP Kuhn et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival
O Castro et al.
BLOOD (2003)
Pulmonary endarterectomy: Experience and lessons learned in 1,500 cases
SW Jamieson et al.
ANNALS OF THORACIC SURGERY (2003)
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
D Mukerjee et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery
SM Lowson et al.
CRITICAL CARE MEDICINE (2002)
Pathobiology of pulmonary arterial hypertension
S Eddahibi et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension
JW Chu et al.
CHEST (2002)
Survival in primary pulmonary hypertension - The impact of epoprostenol therapy
VV McLaughlin et al.
CIRCULATION (2002)
Effects of continuous IV prostacyclin in a patient with pulmonary veno-occlusive disease
H Okumura et al.
CHEST (2002)
Severe pulmonary hypertension in patients with severe aortic valve stenosis: Clinical profile and prognostic implications
JF Malouf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension -: Prognostic factors and survival
O Sitbon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Hemodynamic characterization of patients with severe emphysema
SM Scharf et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Inhaled iloprost for severe pulmonary hypertension
H Olschewski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Assessment of survival in patients with primary pulmonary hypertension importance of cardiopulmonary exercise testing
R Wensel et al.
CIRCULATION (2002)
Pulmonary arterial hypertension and type-I glycogen-storage disease:: the serotonin hypothesis
M Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Recent heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): Approaching the asymptote of efficacy?
JR Teerlink
JOURNAL OF CARDIAC FAILURE (2002)
Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension - Open-label pilot study
RJ Barst et al.
CHEST (2002)
Bosentan therapy for pulmonary arterial hypertension
LJ Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension - A double-blind, randomized, placebo-controlled trial
G Simonneau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension
C Rubens et al.
CHEST (2001)
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study
RN Channick et al.
LANCET (2001)
Unexplained pulmonary hypertension in chronic myeloproliferative disorders
D Dingli et al.
CHEST (2001)
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
RC Trembath et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Cardiac involvement in thalassemia intermedia: a multicenter study
A Aessopos et al.
BLOOD (2001)
Balloon atrial septostomy in end-stage pulmonary hypertension guided by a novel intracardiac echocardiographic transducer
M Moscucci et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2001)
BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension
RD Machado et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease
ES Klings et al.
RESPIRATORY RESEARCH (2001)
Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension
RV Aguilar et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family
JR Thomson et al.
JOURNAL OF MEDICAL GENETICS (2000)
HIV-Related pulmonary hypertension - Analytic review of 131 cases
NJ Mehta et al.
CHEST (2000)
Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene
ZM Deng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.
MM Hoeper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension - Comparison with cardiopulmonary exercise testing
S Miyamoto et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
KB Lane et al.
NATURE GENETICS (2000)
Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease
KN Cowan et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
